Craft

Next Science

Stock Price

$0.2

2024-10-04

Market Capitalization

$58.4 M

2024-10-04

Revenue

$22.8 M

FY, 2024

Next Science Summary

Company Summary

Overview
Next Science is a medical technology company. Its primary focus is the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections on human health. The company brings to market a portfolio of products to eliminate biofilms and their incumbent bacteria, fungus, and viruses.
Type
Public
Status
Active
Founded
2012
HQ
Sydney, AU | view all locations
Website
https://www.nextscience.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Matthew Myntti
  • Jon Swanson
  • Aileen Stockburger

    Aileen Stockburger, Non-Executive Director

  • Mark Compton

    Mark Compton, Chair

    LocationsView all

    1 location detected

    • Sydney, NSW HQ

      Australia

      level 19, tower a/821 Pacific Hwy

    Next Science Financials

    Summary Financials

    Revenue (H1, 2025)
    $10.5M
    Gross profit (H1, 2025)
    $9.4M
    Net income (H1, 2025)
    ($4.7M)
    Cash (H1, 2025)
    $971.0K
    EBIT (H1, 2025)
    ($4.3M)
    Enterprise value
    $62.2M

    Footer menu